Mature TLSs are characterized by mature GCs and the presence of FDCs

Mature TLSs are characterized by mature GCs and the presence of FDCs. with diseases, and potential restorative applications of TLSs. Furthermore, we discuss the restorative implications of TLSs, such as Geraniin their part as markers of restorative response and prognosis. Finally, we summarize numerous methods for detecting and focusing on TLSs. Overall, we provide a comprehensive understanding of TLSs and aim to develop more effective therapeutic strategies. Subject terms:Immunotherapy, Applied immunology == Intro == Tertiary lymphoid constructions (TLSs) are structured, non-encapsulated aggregates of lymphoid cells that form in non-lymphoid cells under pathological conditions after birth.1,2TLSs mainly include germinal centers (GCs), surrounding T-cell areas, and distributed PANd+high endothelial venules (HEVs).35TLSs typically form in response to chronic inflammation, such as infections, autoimmune diseases, cells transplants, and cancers.612Recent studies have found a positive correlation between the presence of TLSs and the efficacy of immune checkpoint blockade (ICB) therapy. However, the underlying mechanism remains unclear, and only a minority of individuals benefit from this therapy.6,13,14Moreover, the prognostic value of TLSs has been widely discussed. In conditions that require an enhanced immune response, such as tumor and infectious diseases, the presence and maturation of TLSs generally show more beneficial results.6,1519Conversely, in autoimmune diseases and age-related chronic inflammatory conditions, which involve the immune system attacking self-tissues, the emergence and maturation of TLSs are often associated with poorer prognoses.2022Therefore, TLSs can be seen like a double-edged sword. To fully harness the potential of TLSs, a comprehensive understanding of TLSs is definitely urgently needed. In 1964, Ziff noticed similarities between inflamed rheumatoid synovial cells and lymph nodes, where the main immune response happens.23,24In the early 1970s, Sderstrm et al. found that the structure of thyroid cells in individuals with Hashimotos thyroiditis resembled that of lymph nodes.24,25In 1992, Geraniin Louis Picker and Eugene Butcher formally introduced the concept of tertiary lymphoid organs (TLOs) or tertiary lymphoid tissues (TLTs). At that time, it was believed that TLOs could happen in all cells of the body, except main lymphoid organs (bone marrow and thymus) and secondary lymphoid organs (lymph nodes, spleen, and gut-associated lymphoid cells). TLOs were regarded as sites where memory space lymphocytes and effector precursor cells could be re-stimulated by antigens, or where B cells and T cells could carry out terminal reactions. However, they believed that TLOs are an unorganized constructions composed of a small number of lymphocytes. If long-term activation leads to the IGFBP3 formation of lymph node-like constructions in TLOs, they have transformed into secondary lymphoid constructions.9,26In 1996, Kratz et al. shown that lymphotoxin could induce the formation of lymphoid cells in chronic inflammatory conditions. This is similar to the induction signals for lymphoid organogenesis during embryonic development. Therefore, they termed the de novo formation process of organized lymphoid cells lymphoid neogenesis in chronic swelling.27,28In 1998, Wagner et al. proposed the concept of ectopic lymphoid cells (ELTs), because individuals with rheumatoid synovitis experienced follicle-like constructions in their synovial cells that resembled secondary lymphoid follicles. They also clarified the cellular parts required for GC formation within it.29In 2001, Seisuke et al. found out GCs in rheumatoid synovitis with the same morphology and function as lymph node GCs. Thus, they proposed the term tertiary lymphoid constructions (TLSs).30In 2015, Jin et Geraniin al. explained the characteristics of TLSs in breast cancer.31Some studies also refer to TLSs as ectopic lymphoid organs or ectopic lymphoid structures.32,33In the 1st decade of the 21st century, research on TLSs mainly focused on chronic inflammation, autoimmune diseases, and immune rejection after organ transplantation. In 2008, TLSs were reported to be associated with a better prognosis in non-small cell lung malignancy, marking the 1st finding of TLSs in tumors.34ICB has been a focal point in tumor treatment, and in 2015, Giraldo et al. 1st linked the presence of TLSs with the effectiveness of ICB therapy.35Subsequent research further confirmed that the presence of TLSs can predict the positive effects of ICB treatment.3638Since 2020, this topic has received wider attention and has become a hot topic in the field of TLS study.6,12,39However, our understanding of TLSs is still very limited. (Fig.1). == Fig. 1. == Milestone events of the discovery and development of TLSs. Important milestones in tertiary lymphoid.